InsidersTradesSigma
휴메딕스 Stock: price and management transactions · South Korea · DART (FSS)
Follow the 휴메딕스 share price and the full management transaction log of the company, a listed issuer based in South Korea. Shares are listed on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 휴메딕스 has published 29 insider filings. Market capitalisation: €314.2bn. The latest transaction was filed on 16 March 2026 (Other). Among the most active insiders: 배준규. Every trade is accessible without an account.
29
Insider Decl.
0
Thresholds
·
8 ops.
Buy Volume
·
1 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 휴메딕스 Strong Buy (bullish), based on 1 analysts. Average price target: ₩62,000.
7Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 439 of 25,484 companies
84.7
score / 100
Value93
Quality77
FCF yld13%
Earn yld17%
EV/EBITDA4.0x
ROE7.3%
Gross mgn47%
Net mgn30%
Debt/EBITDA0.0x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 16 March 2026
Declarations29 total
25 of 29 declarations